Ullet index:Nxera Pharma Co., Ltd.:4565

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Nxera Pharma Co., Ltd. Go to web site 4565 Medicals 東証プライム December 1, 2000 2004.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

Nxera Pharma Co., Ltd. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 66,810
plusup
57,936
plusup
57,468
plusup
52,381
plusup
45,075
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp -7,193
plusdown
382
plusdown
1,017
plusdown
1,479
plusup
1,432
plus
Operating Cash Flow(OFC)Help -5,273
plusdown
9,952
plusup
7,095
plusup
4,672
plusup
3,441
plus
Free Cash Flow(FCF)Help -69,064
plusdown
10,995
plusup
7,373
plusup
4,522
plusup
3,195
plus
OFC - Net IncomeHelp 76
plusdown
94
plusdown
95
plusup
91
plusdown
92
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -12.58%
plusdown
17.15%
plusup
13.55%
plusdown
13.59%
plusdown
30.86%
plus
Current Assets / Amount of SalesHelp 328.40%
plusdown
372.66%
plusup
295.67%
plusdown
388.91%
plusup
114.65%
plus
Free Cash Revenue RatioHelp -541.00%
plusdown
70.62%
plusup
41.63%
plusdown
51.14%
plusup
32.85%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Nxera Pharma Co., Ltd.

Company where related level is highHelp

Medrx Co.,Ltd.
ONO PHARMACEUTICAL CO.,LTD.
Fuji Pharma Co.,Ltd.
NANO MRNA Co., Ltd.
Noile-Immune Biotech Inc.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
MIZUHO MEDY CO.,LTD.
RaQualia Pharma Inc.
JCR Pharmaceuticals Co.,Ltd.
Renascience Inc.